Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

Premature Aging and Type 2 Diabetes Mellitus: an Increased Risk of Cardiomyopathy?

Authors not listed

Hospices Civils de Lyon · 2009

Abstract

The potential clinical implications of this study are to optimise the selection of a population at risk for developing a diabetic cardiomyopathy among diabetic patients in order to develop early therapeutic strategies to prevent the left ventricular remodelling. Therefore, the originality of this project is to hypothesize that : * Diabetes mellitus is often associated with a premature aging syndrome * Cellular senescence(definition) may potentiate the mechanisms that are involved in decreasing myocardial contractility in DM and, * DM associated to premature aging may increase the risk of developing a cardiomyopathy Thus, the modulation of telomerase activity and the control of telomere(definition) length, together with the attenuation of the formation of reactive oxygen species, might represent important new targets in order to develop therapeutic tools in prevention of diabetic cardiomyopathy.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-05-29 MST

Cite this

APA
Anonymous. (2009). Premature Aging and Type 2 Diabetes Mellitus: an Increased Risk of Cardiomyopathy?. <em>Hospices Civils de Lyon</em>. https://clinicaltrials.gov/study/NCT01536808
Vancouver
Anonymous. Premature Aging and Type 2 Diabetes Mellitus: an Increased Risk of Cardiomyopathy?. Hospices Civils de Lyon. 2009.
BibTeX
@misc{anon2009Premat, title = {Premature Aging and Type 2 Diabetes Mellitus: an Increased Risk of Cardiomyopathy?}, author = {Anonymous}, journal = {Hospices Civils de Lyon}, year = {2009}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings